Solid biosciences reports inducement grant under nasdaq listing rule 5635(c)(4)

Charlestown, mass., july 01, 2024 (globe newswire) -- solid biosciences inc. (nasdaq: sldb) (the “company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a grant of 11,847 restricted stock units (“rsus”) to one newly hired employee.

SLDB Ratings Summary

SLDB Quant Ranking